Intravenous tolerization with type II collagen induces interleukin-4- and interleukin-10-producing CD4+ T cells

Immunology

Volumn 97, Issue 3, 1999, Pages 466-473

  Gumanovskaya, M L ^a,b   Myers, Linda Kay ^a   Rosloniec, E F ^a,b   Stuart, J M ^a,b   Kang, A H ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTHRITIS; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; COLLAGEN; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INJECTIONS, INTRAVENOUS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKINS; MALE; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN;

EID: 0032972636     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00778.x     Document Type: Article

References (39)

1. 1. CREMER M.A., HERNANDEZ A.D., STUART J.M., TOWNES A.S. & KANG A.H. (1983) Collagen-induced arthritis in rats: antigen specific suppression of arthritis and immunity by intravenously injected native type 11 collagen. J Immunol 131, 2995.
2. 2. NAGLER-ANDERSON C.N., BOBER L.A., ROBINSON M.E., SISKIND G.W. & THORBECKE G.J. (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83, 7443.
3. 3. THOMPSON H.S. & STAINES N.A. (1986) Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 64, 581.
4. 4. WOOLEY P.H., LUTHRA H.S., SINGH S., HUSE A., STUART J.M. & DAVID C.S. (1984) Passive transfer of arthritis in mice by human anti-type II collagen antibody. Mayo Clinic Proc 59, 737.
5. 5. MYERS L., SEYER J., STUART J. & KANG A. (1997) Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology 90, 161.
6. 6. MYERS L.K., TERATO K., STUART J.M., SEYER J.M., DAVID C.S. & KANG A.H. (1993) T cell epitopes of type II collagen which regulate murine collagen-induced arthritis. J Immunol 151, 500.
7. 7. KHARE S.D., KRCO C.J., GRIFFITHS M.M., LUTHRA H.S. & DAVID C.S. (1995) Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 155, 3653.
8. 8. MYERS L.K., STUART J.M. & KANG A.H. (1989) A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J Immunol 143, 3976.
9. 9. CHEN Y., KUCHROO V.K., INOBE J., HAFLER D.A. & WEINER H.L. (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237.
10. 10. WEINER H.L., FRIEDMAN A., MILLER A. et al. (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12, 809.
11. 11. SAKAGUCHI S., ERMAK T.H., TODA M. et al. (1994) Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression. J Immunol 152, 1471.
12. 12. ROSLONIEC E.F., KANG A.H., MYERS L.K. & CREMER M.A. (1997) Collagen-induced arthritis. In: Current Protocols in Immunology (eds R. Coico & E. Shevach), p. 15.5.1 24. Wiley & Sons, New York, NY.
13. 13. WOOLEY P.H., LUTHRA H.S., STUART J.M. & DAVID C.S. (1981) Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154, 688.
14. 14. MYERS L.K., STUART J.M., SEYER J.M. & KANG A.H. (1989) Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J Exp Med 170, 1999.
15. 15. MORI L., LOETSCHER H., KAKIMOTO K., BLUETHMANN H. & STEINMETZ M. (1992) Expression of a transgenie T cell receptor beta chain enhances collagen-induced arthritis. J Exp Med 176, 381.
16. 16. SPINELLA D.G., JEFFERS J.R., REIFE R.A. & STUART J.M. (1991) The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis. Immunogenetics 34, 23.
17. 17. BANERJEE S., HAQQI T.M., LUTHRA H.S., STUART J.M. & DAVID C.S. (1988) Possible role of V β T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med 167, 832.
18. 18. TANG H. & BRALEY-MULLEN H. (1997) Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Int Immunol 9, 679.
19. 19. POPE L., PATTERSON P.Y. & MILLER S.D. (1992) Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol 37, 177.
20. 20. GAUR A., WIERS B., LIU A., ROTHBARD J. & FATHMAN C.G. (1992) Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258, 1491.
21. 21. CHEN Y., INOBE J., MARKS R., GONNELLA P., KUCHROO V.K. & WEINER H.L. (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance [published erratum appears in Nature 1995 Sep 21; 377 (6546): 257]. Nature 376, 177.
22. 22. SCHWARTZ R.H. (1996) Models of T cell anergy: is there a common molecular mechanism? [Comment.] J Exp Med 184, 1.
23. 23. QUILL H. (1996) Anergy as a mechanism of peripheral T cell tolerance. J Immunol 156, 1325.
24. 24. ENGLERT M.E., LANDES M.J., ORONSKY A.L. & KERWAR S.S. (1984) Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide alpha I (II) CB10. Cell Immunol 87, 357.
25. 25. KAGEYAMA Y., KOIDE Y., YOSHIDA A. et al. (1998) Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 161, 1542.
26. 26. MANOURY-SCHWARTZ B., CHIOCCHIA G., BESSIS N. et al. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 158, 5501.
27. 27. VERMEIRE K., HEREMANS H., VANDEPUTTE M., HUANG S., BILLIAU A. & MATTHYS P. (1997) Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 158, 5507.
28. 28. DE WAAL MALEFYI R., HAANEN J., SPITS H. et al. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174, 915.
29. 29. DE WAAL MALEFYI R., YSSEL H. & DE VRIES J.E. (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150, 4754.
30. 30. GROUX H., BIGLER M., DE VRIES J.E. & RONCAROLO M.G. (1996) Interlcukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells [sec comments]. J Exp Med 184, 19.
31. 31. DING L., LINSLEY P.S., HUANG L.Y., GERMAIN R.N. & SHEVACH E.M. (1993) IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151, 1224.
32. 32. GAO Q., CHEN N., ROUSE T.M. & FIELD E.H. (1996) The role of interleukin-4 in the induction phase of allogeneic neonatal tolerance. Transplantation 62, 1847.
33. 33. MARCELLETTI J.F., OHARA J.I. & KATZ D.H. (1991) Collagen-induced arthritis in mice: Relationship of collagen-specific and total IgE synthesis to disease. J Immunol 147, 4185.
34. 34. KANAKA Y., OTSUKA T., HOTOKEBUCHI T. et al. (1996) Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res 45, 283.
35. 35. WALMSLEY M., KATSIKIS P.D., ABNEY E. et al. (1996) Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39, 495.
36. 36. FRIEDMAN A. & WEINER H.L. (1994) Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91, 6688.
37. 37. KAPP J.A. & KE Y. (1997) The role of gammadelta TCR-bearing T cells in oral tolerance. Res Immunol 148, 561.
38. 38. MILLER A., LIDER O., ROBERTS A.B., SPORN M.B. & WEINER H.L. (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 89, 421.
39. 39. CHEN Y., INOBE J. & WEINER H.L. (1997) Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell Immunol 178, 62.